Sunesis Pharmaceuticals (SNSS) Misses Q3 Views
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
Loss from operations: -9.99M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Financial Fact:
Loss from operations: -9.99M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q3 EPS of ($0.37), $0.24 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $265 thousand versus the consensus estimate of $4.17 million.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip
- Dollar Tree stock falls despite earnings beat
- Dollar General (DG) Tops Q2 EPS by 48c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
